CD4 and neoplasm: Tumor-infiltrating lymphocyte (TIL) analysis revealed that the proportions, but not activation or cytotoxicity, of CD4+ and CD8+ T cells were significantly decreased in Ankrd52-null tumors (Fig. 2h, I; Supplementary Fig. 5b–g).